86 related articles for article (PubMed ID: 20678960)
1. Nurse led electronic toxicity scoring in head and neck radiotherapy.
Fox E; Barrett-McNeil K; Khoo LH; Middleton M
Eur J Oncol Nurs; 2011 Apr; 15(2):112-7. PubMed ID: 20678960
[TBL] [Abstract][Full Text] [Related]
2. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
[TBL] [Abstract][Full Text] [Related]
3. A study to evaluate nurse-led on-treatment review for patients undergoing radiotherapy for head and neck cancer.
Wells M; Donnan PT; Sharp L; Ackland C; Fletcher J; Dewar JA
J Clin Nurs; 2008 Jun; 17(11):1428-39. PubMed ID: 18093117
[TBL] [Abstract][Full Text] [Related]
4. Acute toxicities experienced during simultaneous integrated boost intensity-modulated radiotherapy in head and neck cancers--experience from a north Indian regional cancer centre.
Chakraborty S; Ghoshal S; Patil V; Oinam A; Suresh S
Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):676-86. PubMed ID: 19748768
[TBL] [Abstract][Full Text] [Related]
5. Pattern analysis of acute mucosal reactions in patients with head and neck cancer treated with conventional and accelerated irradiation.
Wygoda A; Maciejewski B; Skladowski K; Hutnik M; Pilecki B; Golen M; Rutkowski T
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):384-90. PubMed ID: 18374510
[TBL] [Abstract][Full Text] [Related]
6. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
[TBL] [Abstract][Full Text] [Related]
7. Late esophageal toxicity after radiation therapy for head and neck cancer.
Chen AM; Li BQ; Jennelle RL; Lau DH; Yang CC; Courquin J; Vijayakumar S; Purdy JA
Head Neck; 2010 Feb; 32(2):178-83. PubMed ID: 19536858
[TBL] [Abstract][Full Text] [Related]
8. The changed meaning of food: Physical, social and emotional loss for patients having received radiation treatment for head and neck cancer.
McQuestion M; Fitch M; Howell D
Eur J Oncol Nurs; 2011 Apr; 15(2):145-51. PubMed ID: 20864401
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Acute Radiation Mucositis using an Oral Mucosal Dose Surface Model in Carbon Ion Radiotherapy for Head and Neck Tumors.
Musha A; Shimada H; Shirai K; Saitoh J; Yokoo S; Chikamatsu K; Ohno T; Nakano T
PLoS One; 2015; 10(10):e0141734. PubMed ID: 26512725
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
11. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
12. Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone.
Poulsen MG; Riddle B; Keller J; Porceddu SV; Tripcony L
Radiother Oncol; 2008 May; 87(2):253-9. PubMed ID: 18410976
[TBL] [Abstract][Full Text] [Related]
13. Late oral complications following radiotherapy for head and neck cancers.
Chua DT; Tian Y; Wei WI
Expert Rev Anticancer Ther; 2007 Sep; 7(9):1215-24. PubMed ID: 17892422
[TBL] [Abstract][Full Text] [Related]
14. Radiation treatment breaks and ulcerative mucositis in head and neck cancer.
Russo G; Haddad R; Posner M; Machtay M
Oncologist; 2008 Aug; 13(8):886-98. PubMed ID: 18701763
[TBL] [Abstract][Full Text] [Related]
15. Randomized clinical trial on continuous 7-days-a-week postoperative radiotherapy for high-risk squamous cell head-and-neck cancer: a report on acute normal tissue reactions.
Suwinski R; Bankowska-Wozniak M; Majewski W; Sowa A; Idasiak A; Ziolkowska E; Windorbska W; Tarnawski R; Skladowski K; Maciejewski B
Radiother Oncol; 2005 Oct; 77(1):58-64. PubMed ID: 16157401
[TBL] [Abstract][Full Text] [Related]
16. Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study.
Lin LC; Que J; Lin LK; Lin FC
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):745-50. PubMed ID: 16751063
[TBL] [Abstract][Full Text] [Related]
17. Assessing the effectiveness of Dead Sea products as prophylactic agents for acute radiochemotherapy-induced skin and mucosal toxicity in patients with head and neck cancers: a phase 2 study.
Matceyevsky D; Hahoshen NY; Vexler A; Noam A; Khafif A; Ben-Yosef R
Isr Med Assoc J; 2007 Jun; 9(6):439-42. PubMed ID: 17642390
[TBL] [Abstract][Full Text] [Related]
18. Dose-response relations for stricture in the proximal oesophagus from head and neck radiotherapy.
Alevronta E; Ahlberg A; Mavroidis P; al-Abany M; Friesland S; Tilikidis A; Laurell G; Lind BK
Radiother Oncol; 2010 Oct; 97(1):54-9. PubMed ID: 20557965
[TBL] [Abstract][Full Text] [Related]
19. Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer.
Nuyts S; Dirix P; Hermans R; Poorten VV; Delaere P; Weltens C; Van den Bogaert W
Head Neck; 2007 Aug; 29(8):720-30. PubMed ID: 17315171
[TBL] [Abstract][Full Text] [Related]
20. Mucositis pain induced by radiation therapy: prevalence, severity, and use of self-care behaviors.
Wong PC; Dodd MJ; Miaskowski C; Paul SM; Bank KA; Shiba GH; Facione N
J Pain Symptom Manage; 2006 Jul; 32(1):27-37. PubMed ID: 16824982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
